Chronisch entzündliche Darmerkrankungen und Reproduktion - Aktuelles zu Datenlage und Behandlungskonzepten

 

 Buy Article Permissions and Reprints

Zusammenfassung

Die Inzidenzen der chronisch entzündlichen Darmerkrankungen Morbus Crohn und Colitis ulcerosa sind ansteigend. Aufgrund der relativ hohen Inzidenz bei Patientinnen im reproduktiven Alter sowie verbesserter medikamentöser und chirurgischer Methoden sind geburtshilflich Tätige häufiger mit Fragestellungen zur optimalen Betreuung vor und während einer Schwangerschaft konfrontiert. Die vorliegende Übersichtsarbeit soll einerseits den aktuellen Kenntnisstand im Hinblick auf Kinderwunsch und Schwangerschaftsbetreuung von Patientinnen mit chronisch entzündlichen Darmerkrankungen darstellen, andererseits therapeutische Optionen im Hinblick auf ihre Anwendbarkeit in Gravidität und Stillzeit überprüfen.

Abstract

The incidence of inflammatory bowel diseases such as ulcerative colitis and Crohn's disease is rising. Due to their relatively high incidence in the reproductive period and improved conservative and surgical options, obstetricians are more frequently being confronted with questions concerning the optimal therapy before and during the pregnancy of patients with inflammatory bowel diseases. It is the aim of this review to present the current state of knowledge on fertility and medical care during pregnancy and to discuss the therapeutic options with regard to their applicability in pregnancy and during the period of breast feeding in patients with ulcerative colitis and Crohn's disease.

Literatur

• 1 Binder V. Genetic epidemiology in inflammatory bowel disease.  Dig Dis. 1998;  16 351-355
  CrossrefPubMedGoogle Scholar
• 2 Binder V. Epidemiology of IBD during the twentieth century: an integrated view.  Best Pract Res Clin Gastroenterol. 2004;  18 463-479
  CrossrefPubMedGoogle Scholar
• 3 Leitlinie der Deutschen Gesellschaft für Verdauungs- und Stoffwechselerkrankungen. Diagnostik und Therapie der Colitis ulcerosa. http://www.uni-duesseldorf.de/AWMF/ll/021-009.htm . 
  Google Scholar
• 4 Shivananda S, Lennard-Jones J, Logan R, Fear N, Price A, Carpenter L, van Blankenstein M. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC‐IBD).  Gut. 1996;  39 690-697
  CrossrefPubMedGoogle Scholar
• 5 Leitlinie der Deutschen Gesellschaft für Verdauungs- und Stoffwechselerkrankungen. Diagnostik und Therapie des Morbus Crohn.  Zeitschrift für Gastroenterologie. 2003;  41 19-68
  Article in Thieme ConnectPubMedGoogle Scholar
• 6 McLeod R S. Surgery for inflammatory bowel diseases.  Dig Dis. 2003;  21 168-179
  CrossrefPubMedGoogle Scholar
• 7 Schröder O, Sohn C, Stein J. Gastrointestinal and hepatobiliary complications during pregnancy.  Geburtsh Frauenheilk. 2000;  60 333-344
  Article in Thieme ConnectPubMedGoogle Scholar
• 8 Peeters M, Nevens H, Baert F, Hiele M, de Meyer A M, Vlietinck R, Rutgeerts P. Familial aggregation in Crohn's disease. Increased age, adjusted risk and concordance in clinical characteristics.  Gastroenterology. 1996;  111 597-603
  CrossrefPubMedGoogle Scholar
• 9 Ferrero S, Ragni N. Inflammatory bowel disease: management issues during pregnancy.  Arch Gynecol Obstet. 2004;  270 79-85
  PubMedGoogle Scholar
• 10 Alstead E M, Nelson-Piercy C. Inflammatory bowel disease in pregnancy.  Gut. 2003;  52 159-161
  CrossrefPubMedGoogle Scholar
• 11 Willoughby C P, Truelove S C. Ulcerative colitis and pregnancy.  Gut. 1980;  21 469-474
  CrossrefPubMedGoogle Scholar
• 12 Baird D D, Narendranathan M, Sandler R S. Increased risk of preterm birth for women with inflammatory bowel disease.  Gastroenterology. 1990;  99 987-994
  PubMedGoogle Scholar
• 13 Hudson M, Flett G, Sinclair T S, Brunt P W, Templeton A, Mowat N A. Fertility and pregnancy in inflammatory bowel disease.  Int J Gynaecol Obstet. 1997;  58 229-237
  CrossrefPubMedGoogle Scholar
• 14 Baiocco P J, Korelitz B I. The influence of inflammatory bowel disease and its treatment on pregnancy and fetal outcome.  J Clin Gastroenterol. 1984;  6 211-216
  PubMedGoogle Scholar
• 15 Bradley R J, Rosen M P. Subfertility and gastrointestinal disease: “unexplained” is often undiagnosed.  Obstet Gynecol Surv. 2004;  59 108-117
  CrossrefPubMedGoogle Scholar
• 16 Ording Olsen K, Juul S, Berndtsson I, Oresland T, Laurberg S. Ulcerative colitis: female fecundity before diagnosis, during disease and after surgery compared to a population sample.  Gastroenterology. 2002;  122 15-19
  CrossrefPubMedGoogle Scholar
• 17 Johnson P, Richard C, Ravid A, Spencer L, Pinto E, Hanna M, Cohen Z, McLeod R. Female infertility after ileal pouch-anal anastomosis for ulcerative colitis.  Dis Colon Rectum. 2004;  47 1119-1126
  CrossrefPubMedGoogle Scholar
• 18 Oresland T, Palmblad S, Ellstrom M, Berndtsson I, Crona N, Hulten L. Gynaecological and sexual function related to anatomical changes in the female pelvis after restorative proctocolectomy.  Int J Colorectal Dis. 1994;  9 77-81
  CrossrefPubMedGoogle Scholar
• 19 Asztély M, Palmblad S, Wikland M, Hultén L. Radiological study of changes in the pelvis in women following proctocolectomy.  Int J Colorectal Dis. 1991;  6 103-107
  CrossrefPubMedGoogle Scholar
• 20 Mortier P E, Gambiez L, Karoui M, Cortot A, Paris J C, Quandalle P, Colombel J F. Colectomy with ileorectal anastomosis preserves female fertility in ulcerative colitis.  Gastroenterol Clin Biol. 2006;  30 594-597
  PubMedGoogle Scholar
• 21 Cornish J A, Tan E, Teare J, Teoh T G, Rai R, Darzi A W, Paraskevas P, Clark S K, Tekkis P P. The effect of restorative proctocolectomy on sexual function, urinary function, fertility, pregnancy and delivery: a systematic review.  Dis Colon Rectum. 2007;  50 1128-1138
  CrossrefPubMedGoogle Scholar
• 22 Marri S R, Ahn C, Buchman A L. Voluntary childlessness is increased in women with inflammatory bowel disease.  Inflamm Bowel Dis. 2007;  13 591-599
  CrossrefPubMedGoogle Scholar
• 23 Fielding J F, Cooke W T. Pregnancy and Crohn's disease.  Br Med J. 1970;  2 76-77
  PubMedGoogle Scholar
• 24 Moody G, Probert C S, Srivastava E M, Rhodes J, Mayberry J F. Sexual dysfunction amongst women with Crohn's disease: a hidden problem.  Digestion. 1992;  52 179-183
  PubMedGoogle Scholar
• 25 Hueting W E, Gooszen H G, van Laarhoven C J. Sexual function and continence after ileo pouch anal anastomosis: a comparison between a meta-analysis and a questionnaire survey.  Int J Colorectal Dis. 2004;  19 215-218
  CrossrefPubMedGoogle Scholar
• 26 Bambrick M, Fazio V W, Hull T L, Pucel G. Sexual function following restorative proctocolectomy in women.  Dis Colon Rectum. 1996;  39 610-614
  CrossrefPubMedGoogle Scholar
• 27 Berndtsson I, Oresland T, Hulten L. Sexuality in patients with ulcerative colitis before and after restorative proctocolectomy: a prospective study.  Scand J Gastroenterol. 2004;  39 374-379
  CrossrefPubMedGoogle Scholar
• 28 Damgaard B, Wettergren A, Kirkegaard P. Social and sexual function following ileal pouch-anal anastomosis.  Dis Colon Rectum. 1995;  38 286-289
  CrossrefPubMedGoogle Scholar
• 29 Nielsen O H, Andreasson B, Bondesen S, Jarnum S. Pregnancy in ulcerative colitis.  Scand J Gastroenterol. 1983;  18 735-742
  CrossrefPubMedGoogle Scholar
• 30 Nielsen O H, Andreasson B, Bondesen S, Jacobsen O, Jarnum S. Pregnancy in Crohn's disease.  Scand J Gastroenterol. 1984;  19 724-732
  PubMedGoogle Scholar
• 31 Miller J P. Inflammatory bowel disease in pregnancy. A review.  J Royal Soc Med. 1986;  79 221-229
  PubMedGoogle Scholar
• 32 Nwokolo C U, Tan W C, Andrews H A, Allan R N. Surgical resections in parous patients with distal ileal and colonic Crohn's disease.  Gut. 1994;  35 220-223
  CrossrefPubMedGoogle Scholar
• 33 Castiglione F, Pignata S, Morace F, Sarubbi A, Baratta M A, D'Agostino L, D'Arienzo A, Mazzacca G. Effect of pregnancy on the clinical course of a cohort of women with inflammatory bowel disease.  Ital J Gastroenterol. 1996;  28 199-204
  PubMedGoogle Scholar
• 34 Caprilli R, Gassull M A, Escher J C, Moser G, Munkholm P, Forbes A, Hommes D W, Lochs H, Angelucci E, Cocco A, Vucelic B, Hildebrand H, Kolacek S, Riis L, Lukas M, de Franchis R, Hamilton M, Jantschek G, Michetti P, O'Morain C, Anwar M M, Freitas J L, Mouzas I A, Baert F, Mitchell R, Hawkey C J. European Crohn's and Colitis Organisation . European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.  Gut. 2006;  55 i36-i58
  CrossrefPubMedGoogle Scholar
• 35 Buyon J P. The effects of pregnancy on autoimmune diseases.  J Leukoc Biol. 1998;  63 281-287
  PubMedGoogle Scholar
• 36 Riis L, Vind I, Politi P, Wolters F, Vermeire S, Tsianos E, Freitas J, Mouzas I, Ruiz Ochoa V, O'Morain C, Odes S, Binder V, Moum B, Stockbrugger R, Langholz E, Munkholm P. European Collaborative study group on Inflammatory Bowel Disease . Does pregnancy change the disease course? A study in a European cohort of patients with inflammatory bowel disease.  Am J Gastroenterol. 2006;  101 1539-1545
  CrossrefPubMedGoogle Scholar
• 37 Kitayama T, Funayama Y, Fukushima K, Shibata C, Takahashi K, Ogawa H, Ueno T, Hashimoto A, Sasaki I. Anal function during pregnancy and postpartum after ileal pouch anal anastomosis for ulcerative colitis.  Surg Today. 2005;  35 211-215
  CrossrefPubMedGoogle Scholar
• 38 Lamah M, Scott H J. Inflammatory bowel disease and pregnancy.  Int J Colorectal Dis. 2002;  17 216-222
  PubMedGoogle Scholar
• 39 Fedorkow D M, Persaud D, Nimrod C A. Inflammatory bowel disease: A controlled study of late pregnancy outcome.  Am J Obstet Gynecol. 1989;  160 998-1001
  CrossrefPubMedGoogle Scholar
• 40 Zeldis J B. Pregnancy and inflammatory bowel disease.  West J Med. 1989;  151 168-171
  PubMedGoogle Scholar
• 41 Anderson J B, Turner G M, Williamson R C. Fulminant ulcerative colitis in late pregnancy and the puerperium.  J R Soc Med. 1987;  80 492-494
  PubMedGoogle Scholar
• 42 Mahadevan U. Fertility and pregnancy in the patient with inflammatory bowel disease.  Gut. 2006;  55 1198-1206
  PubMedGoogle Scholar
• 43 Korelitz B I. Inflammatory bowel disease and pregnancy.  Gastroenterol Clin North Am. 1998;  27 213-224
  CrossrefPubMedGoogle Scholar
• 44 Lang E, Schäfer W, Steegmüller K W, Höckel M, Junginger T. Die Perforation bei Morbus Crohn als Komplikation in der Schwangerschaft.  Geburtsh Frauenheilk. 1991;  51 241-243
  PubMedGoogle Scholar
• 45 Roether M, Reichardt H D, Oechsner M G. Erstmanifestation eines Morbus Crohn in der Spätschwangerschaft: Indikation zur Ileozäkalresektion mit nachfolgendem Spontanpartus.  Geburtsh Frauenheilk. 2005;  65 974-977
  Article in Thieme ConnectPubMedGoogle Scholar
• 46 Subhani J M, Hamiliton M I. Review article: The management of inflammatory bowel disease during pregnancy.  Aliment Pharmacol Ther. 1998;  12 1039-1053
  CrossrefPubMedGoogle Scholar
• 47 Hanan I M, Kirsner J B. Inflammatory bowel disease in the pregnant woman.  Clin Perinatol. 1985;  12 669-682
  PubMedGoogle Scholar
• 48 Schade R R, Thiel D HV, Gavaler J S. Chronic idiopathic ulcerative colitis. Pregnancy and fetal outcome.  Dig Dis Sci. 1984;  29 614-619
  CrossrefPubMedGoogle Scholar
• 49 Kornfeld D, Cnattingius S, Ekbom A. Pregnancy outcomes in women with inflammatory bowel disease - A population-based cohort study.  Am J Obstet Gynecol. 1997;  177 942-946
  CrossrefPubMedGoogle Scholar
• 50 Fonager K, Sørensen H T, Olsen J, Dahlerup J F, Rasmussen S N. Pregnancy outcome for women with Crohn's disease: A follow-up study based on linkage between national registries.  Am J Gastroenterol. 1998;  93 2426-2430
  CrossrefPubMedGoogle Scholar
• 51 Norgard B, Fonager K, Sørensen H T, Olsen J. Birth outcomes of women with ulcerative colitis: A nationwide Danish cohort study.  Am J Gastroenterol. 2000;  95 3165-3170
  PubMedGoogle Scholar
• 52 Moser M A, Okun N B, Mayes D C, Bailey R J. Crohn's disease, pregnancy, and birth weight.  Am J Gastroenterol. 2000;  95 1021-1026
  CrossrefPubMedGoogle Scholar
• 53 Bortoli A, Saibeni S, Tatarella M, Prada A, Beretta L, Rivolta R, Politi P, Ravelli P, Imperiali G, Colombo E, Pera A, Daperno M, Carnovali M, de Franchis R, Vecchi M. the Study Group for Inflammatory Bowel Diseases GSMII . Pregnancy before and after the diagnosis of inflammatory bowel diseases: retrospective case-control study.  J Gastroenterol Hepatol. 2007;  22 542-549
  CrossrefPubMedGoogle Scholar
• 54 Rogers R G, Katz V L. Course of Crohn's disease during pregnancy and its effect on pregnancy outcome: A retrospective review.  Am J Perinatol. 1995;  12 262-264
  Article in Thieme ConnectPubMedGoogle Scholar
• 55 Cornish J A, Tan E K, Teare J, Teoh T G, Rai R, Clark S K, Tekkis P P. A Meta-analysis on the influence of inflammatory bowel disease on pregnancy.  Gut. 2007;  56 830-837
  CrossrefPubMedGoogle Scholar
• 56 Dominitz J A, Young J CC, Boyko E J. Outcomes of infants born to mothers with inflammatory bowel disease: A population-based cohort study.  Am J Gastroenterol. 2002;  97 641-648
  CrossrefPubMedGoogle Scholar
• 57 Nørgård B, Puho E, Pedersen L, Czeizel A E, Sørensen H T. Risk of congenital abnormalities in children born to women with ulcerative colitis: a population-based, case-control study.  Am J Gastroenterol. 2003;  98 2006-2010
  PubMedGoogle Scholar
• 58 Teahon K, Pearson M, Levi A J, Bjarnason I. Elemental diet in the management of Crohn's disease during pregnancy.  Gut. 1991;  32 1079-1081
  CrossrefPubMedGoogle Scholar
• 59 Tresadern J C, Falconer G F, Turnberg L A, Irving M H. Successful completed pregnancy in a patient maintained on home parenteral nutrition.  BMJ. 1983;  286 602-603
  PubMedGoogle Scholar
• 60 Czeizel A E, Toth M, Rockenbauer M. Population-based case-control study of folic acid supplementation during pregnancy.  Teratology. 1996;  53 345-351
  CrossrefPubMedGoogle Scholar
• 61 Reddy S I, Wolf J L. Management issues in women with inflammatory bowel disease.  J Am Osteopath Assoc. 2001;  101 (12 Suppl Pt 2) S17-23
  PubMedGoogle Scholar
• 62 Beniada A, Benoist G, Maurel J, Dreyfus M. Inflammatory bowel disease and pregnancy: report of 76 cases and review of the literature.  J Gynecol Obstet Biol Reprod (Paris). 2005;  34 581-588
  CrossrefPubMedGoogle Scholar
• 63 Ilnyckyji A, Blanchard J F, Rawsthorne P, Bernstein C N. Perianal Crohn's disease and pregnancy: Role of the mode of delivery.  Am J Gastroenterol. 1999;  94 3274-3278
  CrossrefPubMedGoogle Scholar
• 64 Brandt L J, Estabrook S G, Reinus J F. Results of a survey to evaluate whether vaginal delivery and episiotomy lead to perineal involvement in women with Crohn's disease.  Am J Gastroenterol. 1995;  90 1918-1922
  PubMedGoogle Scholar
• 65 Remzi F H, Gorgun E, Bast J, Schroeder T, Hammel J, Philipson E, Hull T L, Church J M, Fazio V W. Vaginal delivery after ileal pouch-anal anastomosis: a word of caution.  Dis Colon Rectum. 2005;  48 1691-1699
  CrossrefPubMedGoogle Scholar
• 66 Hahnloser D, Pemberton J H, Wolff B G, Larson D, Harrington J, Farouk R, Dozois R R. Pregnancy and delivery before and after ileal pouch-anal anastomosis for inflammatory bowel disease: immediate and long-term consequences and outcomes.  Dis Colon Rectum. 2004;  47 1127-1135
  PubMedGoogle Scholar
• 67 Katz J A, Pore G. Inflammatory bowel disease and pregnancy.  Inflamm Bowel Dis. 2001;  7 146-157
  CrossrefPubMedGoogle Scholar
• 68 Donaldson R M. Management of medical problems in pregnancy - inflammatory bowel disease.  N Engl J Med. 1985;  312 1616-1619
  PubMedGoogle Scholar
• 69 Warrell D W, Taylor R. Outcome for the foetus of mothers receiving prednisolone during pregnancy.  Lancet. 1968;  1 117-118
  PubMedGoogle Scholar
• 70 Khosla R, Willoughby C P, Jewell D P. Crohn's disease and pregnancy.  Gut. 1984;  25 52-56
  CrossrefPubMedGoogle Scholar
• 71 Porter R J, Stirrat G M. The effects of inflammatory bowel disease on pregnancy: A case-controlled retrospective analysis.  Br J Obstet Gynecol. 1986;  93 1124-1131
  PubMedGoogle Scholar
• 72 Wolfson K, Cohen Z, McLeod R S. Crohn's disease and pregnancy.  Dis Colon Rectum. 1990;  33 869-873
  CrossrefPubMedGoogle Scholar
• 73 Travis S. Advances in therapeutic approaches to ulcerative colitis and Crohn's disease.  Curr Gastroenterol Rep. 2005;  7 475-484
  CrossrefPubMedGoogle Scholar
• 74 Stein R B, Hanauer S B. Comparative tolerability of treatments for inflammatory bowel disease.  Drug Saf. 2000;  23 429-448
  CrossrefPubMedGoogle Scholar
• 75 Craxi A, Pagliarello F. Possible embryotoxicity of sulfasalazine.  Arch Intern Med. 1980;  140 1674
  PubMedGoogle Scholar
• 76 Newman N M, Correy J F. Possible teratogenicity of sulphasalazine.  Med J Aust. 1983;  1 528-529
  PubMedGoogle Scholar
• 77 Hoo J J, Hadro T A, Von Behren P. Possible teratogenicity of sulfasalazine.  N Engl J Med. 1988;  318 1128
  PubMedGoogle Scholar
• 78 Norgard B, Czeizel A E, Rockenbauer M, Olsen J, Sørensen H T. Population-based case control study of the safety of sulfasalazine use during pregnancy.  Aliment Pharmacol Ther. 2001;  15 483-486
  CrossrefPubMedGoogle Scholar
• 79 Czeizel E A, Dudas I. Prevention of the first occurrence of neuraltube defects with folic acid supplementation.  N Engl J Med. 1992;  327 1832-1835
  PubMedGoogle Scholar
• 80 Esbjörner E, Järnerot G, Wranne L. Sulphasalazine and sulphapyridine serum levels in children to mothers treated with sulphasalazine during pregnancy and lactation.  Acta Paediatr Scand. 1987;  76 137-142
  PubMedGoogle Scholar
• 81 Mogadam M, Dobbins W O, Korelitz B I, Ahmed S W. Pregnancy in inflammatory bowel disease: effect of sulfasalazine and corticosteroids on fetal outcome.  Gastroenterology. 1981;  80 72-76
  PubMedGoogle Scholar
• 82 Diav-Citrin O, Park Y H, Veerasuntharam G, Polachek H, Bologa M, Pastuszak A, Koren G. The safety of mesalamine in human pregnancy: a prospective controlled cohort study.  Gastroenterology. 1998;  114 23-28
  PubMedGoogle Scholar
• 83 Marteau P, Tennenbaum R, Elefant E, Lémann M, Cosnes J. Foetal outcome in women with inflammatory bowel disease treated during pregnancy with oral mesalazine microgranules.  Aliment Pharmacol Ther. 1998;  12 1101-1108
  CrossrefPubMedGoogle Scholar
• 84 Schroeder K W. Role of mesalazine in acute and long-term treatment of ulcerative colitis and its complications.  Scand J Gastroenterol Suppl. 2002;  236 42-44
  PubMedGoogle Scholar
• 85 Bell C M, Habal F M. Safety of topical 5-aminosalicylic acid in pregnancy.  Am J Gastroenterol. 1997;  92 2201-2202
  PubMedGoogle Scholar
• 86 Marteau P, Crand J, Devaux C B. Mesalazine in pregnancy: fetal outcome in 76 IBD patients treated with Pentasa.  Gastroenterology. 1995;  108 A871
  PubMedGoogle Scholar
• 87 Habal F M, Hui G, Greenberg G R. Oral 5-aminosalicylic acid for inflammatory bowel disease in pregnancy: safety and clinical course.  Gastroenterology. 1993;  105 1057-1060
  PubMedGoogle Scholar
• 88 http://www.fda.gov/cder/foi/label/2000/20610lbl.pdf
• 89 Hanauer S B. Review article: high-dose aminosalicylates to induce and maintain remissions in ulcerative colitis.  Aliment Pharmacol Ther. 2006;  24 37-40
  CrossrefPubMedGoogle Scholar
• 90 Bressler B, Sands B E. Review article: Medical therapy for fistulizing Crohn's disease.  Aliment Pharmacol Ther. 2006;  24 1283-1293
  CrossrefPubMedGoogle Scholar
• 91 Roe F J. Toxicologic evaluation of metronidazole with particular reference to carcinogenic, mutagenic, and teratogenic potential.  Surgery. 1983;  93 158-164
  PubMedGoogle Scholar
• 92 Greenberg F. Possible metronidazole teratogenicity and clefting.  Am J Med Genet. 1985;  22 825
  CrossrefPubMedGoogle Scholar
• 93 Burtin P, Taddio A, Ariburnu O, Einarson T R, Koren G. Safety of metronidazole in pregnancy: a meta-analysis.  Am J Obstet Gynecol. 1995;  172 525-529
  CrossrefPubMedGoogle Scholar
• 94 Caro-Paton T, Carvajal A, Diego I M, Martin-Arias L H, Alvarez Requejo A, Rodriguez Pinilla E. Is metronidazole teratogenic? A meta-analysis.  Br J Clin Pharmacol. 1997;  44 179-183
  CrossrefPubMedGoogle Scholar
• 95 Heisterberg L, Branebjerg P E. Blood and milk concentrations of metronidazole in mothers and infants.  J Perinat Med. 1983;  11 114-120
  PubMedGoogle Scholar
• 96 Passmore C M, McElnay J C, Rainey E A, D'Arcy P F. Metronidazole excretion in human milk and its effect on the suckling neonate.  Br J Clin Pharmacol. 1988;  26 45-51
  PubMedGoogle Scholar
• 97 Loebstein R, Addis A, Ho E, Andreou R, Sage S, Donnenfeld A E, Schick B, Bonati M, Moretti M, Lalkin A, Pastuszak A, Koren G. Pregnancy outcome following gestational exposure to fluoroquinolones: A multicenter prospective controlled study.  Antimicrob Agents Chemother. 1998;  42 1336-1339
  PubMedGoogle Scholar
• 98 Niebyl J R. Antibiotics and other anti-infective agents in pregnancy and lactation.  Am J Perinatol. 2003;  20 405-414
  Article in Thieme ConnectPubMedGoogle Scholar
• 99 Linseman D A, Hampton L A, Branstetter D G. Quinolone-induced arthropathy in the neonatal mouse. Morphological analysis of articular lesions produced by pipemidic acid and ciprofloxacin.  Fundam Appl Toxicol. 1995;  28 59-64
  CrossrefPubMedGoogle Scholar
• 100 Berkovitch M, Pastuszak A, Garzarian M, Lewis M, Koren G. Safety of the new quinolones in pregnancy.  Obstet Gynecol. 1994;  84 535-538
  PubMedGoogle Scholar
• 101 Harmon T, Burkhart G, Applebaum H. Perforated pseudomembranous colitis in the breast-fed infant.  J Pediatr Surg. 1992;  27 744-746
  CrossrefPubMedGoogle Scholar
• 102 Gardner D K, Gabbe S G, Harter C. Simultaneous concentrations of ciprofloxacin in breast milk and in serum in mother and breast-fed infant.  Clin Pharm. 1992;  11 352-354
  PubMedGoogle Scholar
• 103 Briggs G G, Freeman F R, Yaffe S J. Drugs in Pregnancy and Lactation. 7th ed. Philadelphia, PA; Lippincott, Williams and Wilkins 2005
  Google Scholar
• 104 Nahum G G, Uhl K, Kennedy D L. Antibiotic use in pregnancy and lactation: what is and is not known about teratogenic and toxic risks.  Obstet Gynecol. 2006;  107 1120-1138
  CrossrefPubMedGoogle Scholar
• 105 Alstead E M, Ritchie J K, Lennard-Jones J E, Farthing M J, Clark M L. Safety of azathioprine in pregnancy in inflammatory bowel disease.  Gastroenterology. 1990;  99 443-446
  CrossrefPubMedGoogle Scholar
• 106 Francella A, Dyan A, Bodian C, Rubin P, Chapman M, Present D H. The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study.  Gastroenterology. 2003;  124 9-17
  CrossrefPubMedGoogle Scholar
• 107 Ramsey-Goldman R, Schilling E. Immunosuppressive drug use during pregnancy.  Rheum Clin NA. 1997;  23 149-167
  CrossrefPubMedGoogle Scholar
• 108 Present D H, Meltzer S J, Krumholz M P, Wolke A, Korelitz B I. 6-Mercaptopurine in the management of inflammatory bowel disease.  Ann Intern Med. 1989;  111 641-649
  CrossrefPubMedGoogle Scholar
• 109 Nørgård B, Pedersen L, Christensen L A, Sørensen H T. Therapeutic drug use in women with Crohn's disease and birth outcomes: a Danish nationwide cohort study.  Am J Gastroenterol. 2007;  102 1406-1413
  CrossrefPubMedGoogle Scholar
• 110 Mottet C, Juillerat P, Gonvers J J, Froehlich F, Burnand B, Vader J P, Michetti P, Felley C. Pregnancy and Crohn's disease.  Digestion. 2005;  71 54-61
  CrossrefPubMedGoogle Scholar
• 111 Donnenfeld A E, Pastuszak A, Noah J S, Schick B, Rose N C, Koren G. Methotrexate exposure prior to and during pregnancy.  Teratology. 1994;  49 79-81
  CrossrefPubMedGoogle Scholar
• 112 Briggs G G, Freeman R K, Yaffe S J. Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk. 5th ed. Baltimore; Williams & Wilkins 1998: 702-705
  Google Scholar
• 113 Lloyd M E, Carr M, McElhatton P, Hall G M, Hughes R A. The effects of methotrexate on pregnancy, fertility and lactation.  QJM. 1999;  92 551-563
  CrossrefPubMedGoogle Scholar
• 114 Connell W R. Safety of drug therapy for inflammatory bowel disease in pregnant and nursing women.  Inflamm Bowel Dis. 1996;  2 33-47
  PubMedGoogle Scholar
• 115 Kane S. Managing pregnancy in IBD.  Inflamm Bowel Dis Monitor. 2002;  4 2-11
  PubMedGoogle Scholar
• 116 Johns D G, Rutherford L D, Leighton P C, Vogel C L. Secretion of methotrexate into human milk.  Am J Obstet Gynecol. 1972;  112 978-980
  PubMedGoogle Scholar
• 117 American Academy of Pediatrics . Transfer of drugs and other chemicals into human milk.  Pediatrics. 2001;  108 776-779
  PubMedGoogle Scholar
• 118 Lichtiger A, Present D, Kornbluth A, Gelernt I, Bauer J, Galler G, Michelassi F, Hanauer S. Cyclosporine in severe ulcerative colitis refractory to steroid therapy.  N Engl J Med. 1994;  330 1841-1845
  CrossrefPubMedGoogle Scholar
• 119 Cohen R D, Stein R, Hanauer S B. Intravenous cyclosporine in ulcerative colitis: a five year experience.  Am J Gastrorenterol. 1999;  94 1587-1592
  CrossrefPubMedGoogle Scholar
• 120 Nguyen G C, Harris M L, Dassopoulos T. Insights in immunomodulatory therapies for ulcerative colitis and Crohn's disease.  Curr Gastroenterol Rep. 2006;  8 499-505
  CrossrefPubMedGoogle Scholar
• 121 Armenti V T, Moritz M J, Davison J M. Drug safety issues in pregnancy following transplantation and immunosuppression: effects and outcomes.  Drug Saf. 1998;  19 219-232
  CrossrefPubMedGoogle Scholar
• 122 Bertschinger P, Himmelmann A, Risti B, Follath F. Cyclosporine treatment of severe ulcerative colitis during pregnancy.  Am J Gastroenterol. 1995;  90 330
  PubMedGoogle Scholar
• 123 Marion J F, Rubin P H, Lichtiger S. et al . Cyclosporine is safe for severe colitis complicating pregnancy.  Am J Gastroenterol. 1996;  91 1975
  PubMedGoogle Scholar
• 124 Flechner S M, Katz A R, Rogers A J, van Buren C, Kahan B D. The presence of cyclosporin in body tissues and fluids during pregnancy.  Am J Kidney Dis. 1985;  5 60-63
  PubMedGoogle Scholar
• 125 Munoz-Flores-Thiagarajan K D, Easterling T, Davis C, Bond E F. Breast-feeding by a cyclosporine-treated mother.  Obstet Gynecol. 2001;  97 816-818
  CrossrefPubMedGoogle Scholar
• 126 Thiru Y, Bateman D N, Coulthard M G. Successful breast feeding while mother was taking cyclosporin.  BMJ. 1997;  315 463
  PubMedGoogle Scholar
• 127 Gonzalez-Lama Y, Gisbert J P, Mate J. The role of tacrolimus in inflammatory bowel disease: a systematic review.  Dig Dis Sci. 2006;  51 1833-1840
  CrossrefPubMedGoogle Scholar
• 128 Ng S C, Arebi N, Kamm M A. Medium-term results of oral tacrolimus treatment in refractory inflammatory bowel disease.  Inflamm Bowel Dis. 2007;  13 129-134
  CrossrefPubMedGoogle Scholar
• 129 Kainz A, Harabacz I, Cowlrick I S, Gadgil S D, Hagiwara D. Review of the course and outcome of 100 pregnancies in 84 women treated with tacrolimus.  Transplantation. 2000;  70 1718-1721
  CrossrefPubMedGoogle Scholar
• 130 Jain A, Venkataramanan R, Fung J J, Gartner J C, Lever J, Balan V, Warty V, Starzl T E. Pregnancy after liver transplantation under tacrolimus.  Transplantation. 1997;  64 559-565
  PubMedGoogle Scholar
• 131 French A E, Soldin S J, Soldin O P, Koren G. Milk transfer and neonatal safety of tacrolimus.  Ann Pharmacother. 2003;  37 815-818
  CrossrefPubMedGoogle Scholar
• 132 Gardiner S J, Begg E J. Breastfeeding during tacrolimus therapy.  Obstet Gynecol. 2006;  107 453-455
  CrossrefPubMedGoogle Scholar
• 133 Korelitz B I. Pregnancy, fertility, and inflammatory bowel disease.  Am J Gastroenterol. 1985;  80 365-370
  PubMedGoogle Scholar
• 134 Modigliani R. Drug therapy for ulcerative colitis during pregnancy.  Eur J Gastroenterol Hepatol. 1997;  9 854-857
  PubMedGoogle Scholar
• 135 Bulmash J M. Systemic lupus erythematosus and pregnancy.  Obstet Gynecol Ann. 1978;  7 153-194
  PubMedGoogle Scholar
• 136 Bulmash J M. Rheumatoid arthritis and pregnancy.  Obstet Gynecol Ann. 1979;  8 223-276
  PubMedGoogle Scholar
• 137 Fitzsimons R, Greenberger P A, Patterson R. Outcome of pregnancy in women requiring corticosteroids for severe asthma.  J Allergy Clin Immunol. 1986;  78 349-353
  PubMedGoogle Scholar
• 138 Pinsky L, DiGeorge A M. Cleft palate in the mouse: a teratogenic index of glucocorticoid potency.  Science. 1965;  147 402-403
  CrossrefPubMedGoogle Scholar
• 139 Fraser F C, Sajoo A. Teratogenic potential of corticosteroids in humans.  Teratology. 1995;  51 45-46
  CrossrefPubMedGoogle Scholar
• 140 Rodriguez-Pinella E, Martinez-Frias M L. Corticosteroids during pregnancy and oral clefts: a case control study.  Teratology. 1998;  58 2-5
  CrossrefPubMedGoogle Scholar
• 141 Beitens I Z, Bayarrd F, Ances I G, Kowarski A, Migeon C J. The transplacental passage of prednisone and prednisolone in pregnancy near term.  J Pediatr. 1972;  81 936-945
  PubMedGoogle Scholar
• 142 Armenti V T, Moritz M J, Cardonick E H, Davison J M. Immunosuppression in pregnancy: choices for infant and maternal health.  Drugs. 2002;  62 2361-2375
  CrossrefPubMedGoogle Scholar
• 143 Burakoff R, Opper F. Pregnancy and nursing.  Gastroenterol Clin N Am. 1995;  24 689-698
  PubMedGoogle Scholar
• 144 Khanna D, McMahon M, Furst D E. Safety of tumor necrosis factor-alpha antagonists.  Drug Saf. 2004;  27 307-324
  CrossrefPubMedGoogle Scholar
• 145 Osterman M T, Lichtenstein G R. Current and future anti-TNF therapy for inflammatory bowel disease.  Curr Treat Options Gastroenterol. 2007;  10 195-207
  CrossrefPubMedGoogle Scholar
• 146 Baumgart D C, Sandborn W J. Inflammatory bowel disease: clinical aspects and established and evolving therapies.  Lancet. 2007;  369 1641-1657
  CrossrefPubMedGoogle Scholar
• 147 Vesga L, Terdiman J P, Mahadevan U. Adalimumab use in pregnancy.  Gut. 2005;  54 890
  CrossrefPubMedGoogle Scholar
• 148 Roux C H, Brocq O, Breuil V, Albert C, Euller-Ziegler L. Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-alpha therapy.  Rheumatology (Oxford). 2007;  46 695-698
  PubMedGoogle Scholar
• 149 Lichtenstein G, Cohen R D, Feagan B G, Sandborn W, Salzberg B, Chen D, Diamond R. Safety of infliximab in Crohn's disease: data from the 5000-patient TREAT registry.  Gastroenterology. 2004;  126 A54
  PubMedGoogle Scholar
• 150 Katz J A, Antoni C, Keenan G F, Smith D E, Jacobs S J, Lichtenstein G R. Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis.  Am J Gastroenterol. 2004;  99 2385-2392
  CrossrefPubMedGoogle Scholar
• 151 Mahadevan U, Kane S, Sandborn W J, Cohen R D, Hanson K, Terdiman J P, Binion D G. Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease.  Aliment Pharmacol Ther. 2005;  21 733-738
  CrossrefPubMedGoogle Scholar
• 152 Vasiliauskas E A, Church J A, Silverman N, Barry M, Targan S R, Dubinsky M C. Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn.  Clin Gastroenterol Hepatol. 2006;  4 1255-1258
  CrossrefPubMedGoogle Scholar
• 153 Shrim A, Koren G. Tumour necrosis factor alpha and use of infliximab. Safety during pregnancy.  Can Fam Physician. 2005;  51 667-668
  PubMedGoogle Scholar
• 154 Einarson A, Mastroiacovo P, Arnon J, Ornoy A, Addis A, Malm H, Koren G. Prospective, controlled, multicentre study of loperamide in pregnancy.  Can J Gastroenterol. 2000;  14 185-187
  PubMedGoogle Scholar
• 155 Hagemann T M. Gastrointestinal medications and breastfeeding.  J Hum Lact. 1998;  14 259-262
  PubMedGoogle Scholar
• 156 Levi A J, Fisher A M, Hughes L, Hendry W F. Male infertility due to sulphasalazine.  Lancet. 1979;  2 276-278
  PubMedGoogle Scholar
• 157 Toth A. Reversible toxic effect of salicylazosulfapyridine on semen quality.  Fertil Steril. 1979;  31 538-540
  PubMedGoogle Scholar
• 158 Birnie G G, McLeod T I, Watkinson G. Incidence of sulphasalazine-induced male infertility.  Gut. 1981;  22 452-455
  CrossrefPubMedGoogle Scholar
• 159 Shaffer J L, Kershaw A, Berrisford M H. Sulphasalazine-induced infertility reversed on transfer to 5-aminosalicylic acid.  Lancet. 1984;  1 1240
  PubMedGoogle Scholar
• 160 Zelissen P M, van Hattum J, Poen H, Scholten P, Gerritse R, te Velde E R. Influence of salazosulphapyridine and 5-aminosalicylic acid on seminal qualities and male sex hormones.  Scand J Gastroenterol. 1988;  23 1100-1104
  CrossrefPubMedGoogle Scholar
• 161 Mahadevan U, Terdiman J P, Aron J, Jacobsohn S, Turek P. Infliximab and semen quality in men with inflammatory bowel disease.  Inflamm Bowel Dis. 2005;  11 395-399
  CrossrefPubMedGoogle Scholar
• 162 Rajapakse R O, Korelitz B I, Zlatanic J, Baiocco P J, Gleim G W. Outcome of pregnancies when fathers are treated with 6-mercaptopurine for inflammatory bowel disease.  Am J Gastroenterol. 2000;  95 684-688
  CrossrefPubMedGoogle Scholar
• 163 Kane S V. What's good for the goose should be good for the gander - 6-MP use in fathers with inflammatory bowel disease.  Am J Gastroenterol. 2000;  95 581-582
  PubMedGoogle Scholar
• 164 Burnell D, Mayberry J, Calcraft B J, Morris J S, Rhodes J. Male fertility in Crohn's disease.  Postgrad Med J. 1986;  62 269-272
  PubMedGoogle Scholar
• 165 Narendranathan M, Sandler R S, Suchindran C M, Savitz D A. Male infertility in inflammatory bowel disease.  J Clin Gastroenterol. 1989;  11 403-406
  CrossrefPubMedGoogle Scholar
• 166 Farthing M J, Dawson A M. Impaired semen quality in Crohn's disease - drugs, ill health, or undernutrition?.  Scand J Gastroenterol. 1983;  18 57-60
  PubMedGoogle Scholar
• 167 El-Tawil A M. Zinc deficiency in men with Crohn's disease may contribute to poor sperm function and male infertility.  Andrologia. 2003;  35 337-341
  CrossrefPubMedGoogle Scholar

Michael K. Bohlmann

Klinik für Frauenheilkunde und Geburtshilfe
Universitätsklinikum Schleswig-Holstein - Campus Lübeck

Ratzeburger Allee 160

23538 Lübeck

Email: michael.bohlmann@uk-sh.de